TABLE 3.
Univariate and multivariate analysis of overall survival in 89 CRC patients
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| HR (95% CI) | P‐value | HR (95% CI) | P‐value | |
| Age (yr) | 1.07 (0.726‐1.818) | .623 | ||
| Gender | 0.921 (0.693‐1.632) | .534 | ||
| Tumor location | 1.026 (0.902‐1.307) | .321 | ||
| T classification | 2.230 (1.655‐5.030) | <.001* | 1.601 (0.972‐2.401) | .060 |
| N classification | 2.363 (1.593‐3.126) | <.001* | 1.253 (0.439‐1.814) | .307 |
| M classification | 9.753 (6.793‐15.773) | <.001* | 7.309 (3.894‐11.378) | <.001* |
| AJCC stage (III‐IV vs I‐II) | 6.126 (3.225‐13.608) | <.001* | 2.363 (1.075‐8.021) | .034* |
| Differentiation | 0.872 (0.545‐1.624) | .184 | ||
| Recurrence | 2.343 (1.625‐5.203) | <.001* | 2.674 (1.589‐4.079) | <.001* |
| lncARSR | 5.435 (3.374‐10.687) | <.001* | 3.250 (1.596‐6.716) | .001* |
Abbreviations: CI, confidence interval; HR, hazard ratio.
*
P < .05 indicates that the 95% CI of HR was not including 1.